FIG. 1. Goldmann visual fields at presentation (upper)
, after 3 days of treatment with high-dose methylprednisolone (center), and 1 year (lower) after ON decompression. The initially small area of preserved vision enlarged significantly after treatment with steroid drugs and remained improved after surgical treatment 1 year later. revealed normal flow times but significant capillary leakage in the right optic disc.
Neuroradiological Studies. Computerized tomography scanning ( Fig. 2 ) revealed diffuse hyperostosis resulting in a thickened calvaria that measured up to 3 cm thick in some areas; only the bisquamous occipital bone was spared. All foramina were significantly narrowed, and the right optic canal in particular was narrowed to less than 2 mm. Sinus spaces were nearly obliterated, and sinus mucous membranes and meninges were diffusely thickened. Sagittal MR imaging (Fig. 3 ) revealed multiple small, circumscribed lesions within the calvaria that were consistent with brown tumors, characteristic of the hypererythropoiesis of chronic anemia. Also observed on MR imaging were abnormal vascular flow voids in the anterior intracranial region, and MR angiography revealed a moyamoya pattern of collateral vascularization. Conventional angiography demonstrated occlusion of the supraclinoidal segment of the internal carotid arteries bilaterally, distal to the origin of the anterior choroidal artery, with collateral reconstitution of the distal anterior and middle cerebral arteries. The proximal and cavernous segments of the internal carotid arteries, and the OphAs, were normal on angiographic studies.
Opening pressure on lumbar puncture was normal at 180 mm H 2 O. Cerebrospinal fluid chemistry and cell counts were normal, and oligoclonal bands were negative. Serum levels of sodium, potassium, bicarbonate, chloride, and glucose were normal. Elevation of the following constituents were noted on serum studies: blood urea nitrogen 50 mg/dl (normal 7-20 mg/dl), creatinine 7 mg/dl (normal 0.7-1.1 mg/dl), calcium 9.5 mg/dl (normal 8.4-10.2 mg/ dl), phosphorus 5.5 mg/dl (normal 2.1-4.3 mg/dl), and parathyroid hormone 701 pg/ml (normal 11-54 pg/ml).
Treatment and Clinical Course. The patient was admitted and treated with intravenously administered high-dose methylprednisolone (250 mg every 6 hours). Within 18 hours of starting treatment, her visual acuity had improved subjectively, and within 3 days it had improved to 20/200. The right central scotoma was reduced in size and she was able to count fingers in all but the superonasal field (Fig. 1  center) .
Because we were concerned that compression of the ON within the optic canal was contributing at least in part to her vision loss, 23 we decided to proceed with surgical decompression of the canal via a right pterional craniotomy. Care was taken throughout the surgery to avoid any hypotension. The bone thickness at the pterion was 2.5 cm, which was well beyond the capability of conventional drills and craniotomes, making entry somewhat challenging. This difficulty was surmounted using handheld burrs and an oscillating saw to complete the cranial opening. The ON and orbital roof were exposed by gentle elevation of the frontal lobe intradurally, and the dorsal aspect of the optic canal was completely opened using a burr (model M8; Midas Rex Inc., Fort Worth, TX) with copious irrigation, microcurette, and a 1-mm Kerrison rongeur. The bone in this location was noted to be 10 mm thick, in contrast with the usual thickness of 1 to 2 mm. The ON sheath was fenestrated with a scalpel and microscissors, and a distinct pallor of the ON was noted.
Postoperative Course. The patient had an uneventful postoperative course with further objective improvement in her right visual field and color vision. Steroid medications were tapered after the 3rd postoperative day. Over the next 12 months, the visual field of her right eye had improved, with only a small central scotoma remaining (Fig.  1 lower) . Her acuity remained stable at 20/200 OD, with a 1.5 log U RAPD. She underwent evaluation for residual parathyroid tissue, but none was found.
Sixteen months after her initial presentation she suffered acute painless vision loss of the left eye. Visual acuity was 20/400 OS, there was a 0.9 to 1.2 log U RAPD, and the visual field was severely constricted. She sought clinical treatment immediately after the onset of symptoms, and treatment was begun with intravenously administered steroids at the same dose as before for 5 days. This was then followed by orally administered prednisone (60 mg/day). With this treatment there was also significant improvement in visual acuity, and ON decompression was not attempted. On subsequent visual examinations her acuity was 20/ 200 OD and 20/30 OS, with a RAPD of 0.6 log U in the left eye. A visual field examination conducted 28 months after her initial presentation, however, showed a significantly more constricted visual field in the left eye than in the right (Fig. 4A) , and at 40 months the visual field loss in her left eye had increased further (Fig. 4B) .
Discussion
The massive calvarial hypertrophy encountered in this patient fits best with a diagnosis of ULO or bighead disease, which has been known to affect animals with hyper-
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Compressive optic neuropathy secondary to renal osteodystrophy parathyroidism induced by diets chronically deficient in calcium and rich in phosphate. 14 It has also been seen in animals with hyperparathyroidism secondary to chronic renal insufficiency. 19 Uremic leontiasis ossea represents an extreme manifestation of renal osteodystrophy in the calvaria and facial bones. Lee, et al., 15 recently described the clinical and radiographic features of ULO in five patients and found only four previous descriptions of this entity in humans. 5, 7, 12, 13, 22 In these cases, maxillary and mandibular hypertrophy dominated the clinical presentation and led to respiratory insufficiency, parotitis, dysphagia, or speech impairment. In all the patients presented by Lee, et al., there was calvarial hypertrophy with marked expansion of the diploic space and numerous diploic nodules typical of brown tumors. The incidence of ULO is unknown, as is the incidence of subclinical craniofacial hypertrophy in cases of chronic uremia and secondary hyperparathyroidism.
The calvarial hypertrophy and neuroforaminal stenosis in our patient resembles the conditions of fibrous dysplasia and osteopetrosis. These two entities commonly present with compressive cranial neuropathies, especially of the second, seventh, and eighth cranial nerves. 1, 4, 10 Vision loss with these two diseases is most commonly progressive, but can be precipitous. The compressive optic neuropathy seen in these two conditions is best treated with ON decompression. 1, 2, 4, 6, [8] [9] [10] [11] 18, 19, 24 Improvement or stabilization of vision has been achieved in 83 to 94% of patients with these disorders who undergo ON decompression for subtotal vision loss. 1, 4, 20 Transient visual worsening after surgery was reported in only one of 16 eyes. It is less clear whether decompressive surgery should be performed prophylactically in patients with these two entities, although it is advocated by some authors because of the low morbidity rate associated with this procedure. 1, 21 In cases of neoplasm, trauma and fibrous dysplasia, visual outcome is better the less impaired vision is at the time of decompression. 3, 4, 6, 16, 17, 20 The use of corticosteroid drugs as an adjunct to treatment of vision loss in compressive optic neuropathy has not been studied in a randomized controlled fashion, although they tend to be widely used. In a recent metaanalysis of steroid treatment compared with decompressive surgery for acute traumatic optic neuropathy, similar outcomes were found with either treatment or both together, and worse outcomes were seen if neither treatment was used. 6 A variety of surgical approaches are available for ON decompression, including the transcranial approach used here, and the transethmoidal approach. In this case the transcranial approach was used because of the marked distortion of the skull base anatomy secondary to bone hypertrophy and the perceived advantage of being able to visualize the ON directly in the suprasellar subarachnoid space as it enters the optic canal. It is our opinion that with this degree of bone thickening, the transethmoidal approach would be extremely challenging. Regardless of the approach, it is essential to decompress the nerve along the entire length of the optic canal and over an adequate width. Most authors also advocate opening the dural sheath and the annulus of Zinn to complete the decompression. 4, 16 This patient also had coincidental moyamoya disease with bilateral occlusion of the supraclinoid segment of her carotid arteries just distal to the origin of the anterior choroidal arteries. Although this underlying disease also could have contributed to the patient's vision loss, the angiogram revealed no abnormalities of the orbital vasculature including the OphA. We believe that a combination of ischemia and ON compression best account for this patient's vision loss. 23 The abrupt onset of vision loss was fundamentally ischemic in nature; however, the ON compression from the bone overgrowth likely contributed to the nerve's vascular compromise. Thus, we believe that ON decompression is justified for this condition.
Interestingly, with the subsequent episode of vision loss involving the contralateral eye, the patient served as her own control. The medically treated eye sustained progressive visual field loss from 28 months to 40 months, and the final examination 40 months after her initial presentation showed a substantially worse visual field outcome in this eye. The eye that did not undergo operation also ended up with a larger RAPD than the one that did. The eye that was nor surgically treated, however, did recover better visual acuity with less impairment of the central fibers. This difference may be due to the fact that the patient sought ophthalmological treatment much sooner after the second episode of vision loss than after the first.
Parathyroidectomy is recommended for treatment of patients with ULO, and it may stabilize the disease, although the long-term outcome of these patients has not been determined. 15 Patients with this disease should be considered to be at risk of compressive cranial neuropathy, and appropriate clinical monitoring should be performed on a regular basis. Until a way is found to reverse the foraminal stenosis medically, we suggest considering treating any compressive cranial neuropathy in these patients with prompt surgical decompression.
Conclusions
Calvarial hypertrophy in renal osteodystrophy, or ULO, has not previously been described as a cause of ON compression. When treated early and aggressively with highdose steroid medications and ON decompression, vision loss can be significantly reversed. Without ON decompression, progressive loss of vision may occur.
